Trial Profile
A Phase II Randomized Trial Comparing TNFerade Biologic With Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2012
Price :
$35
*
At a glance
- Drugs Golnerminogene pradenovec (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors GenVec
- 22 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.